Nepra Foods Inc. Files Final Prospectus in Respect of its Overnight Marketed Financing

Vancouver, British Columbia--(Newsfile Corp. - March 24, 2022) - Nepra Foods Inc. (CSE: NPRA) (FSE: 2P6) (OTCQB: NPRFF) (the "Company" or "Nepra"), creator of nutritious plant-based and allergen-free food, today announced that it has filed a final short form prospectus (the "Prospectus") in connection with its previously announced overnight marketed public offering (the "Offering") of units of the Company (the "Units") in the provinces of British Columbia, Alberta and Ontario.

Pursuant to the underwriting agreement between the Company and Canaccord Genuity Corp. (the "Underwriter"), the Underwriter has agreed to purchase 10,000,000 Units at a price of $0.45 per Unit (the "Offering Price") for aggregate gross proceeds of $4.5 million. All references to currency in this news release are to Canadian dollars.

Each Unit will consist of one common share (a "Common Share") in the capital of the Company and one Common Share purchase warrant (each, a "Warrant"). Each Warrant will entitle the holder to purchase one Common Share at an exercise price of $0.70 for 36 months from the Closing Date (as defined below). If the volume weighted average trading price of the Common Shares on the Canadian Securities Exchange (or such other stock exchange on which the Common Shares are then listed or quoted) is greater than $1.40 for a period of 10 consecutive trading days, the Company may, within 10 business days of the occurrence of such event, accelerate the expiry date of the Warrants by giving written notice (the "Warrant Acceleration Notice") to the holders of the Warrants and issuing a concurrent press release, and, in such case, the expiry date of the Warrants shall be the date specified by the Company in such Warrant Acceleration Notice, provided such date shall not be less than 30 trading days following delivery of such Warrant Acceleration Notice. The Company has applied to list the Warrants on the Canadian Securities Exchange.

The Company has granted the Underwriter an option (the "Over-Allotment Option"), exercisable, in whole or in part, at the sole discretion of the Underwriter by giving notice to the Company at any time and from time to time up to 30 days following the Closing Date, to purchase up to an additional 1,500,000 Units at the Offering Price to cover over-allotments, if any, and for market stabilization purposes.

As consideration for their services in connection with the Offering, the Underwriter will receive consideration comprised of (i) a cash fee equal to 7% of the gross proceeds of the Offering, including gross proceeds, if any, received from the exercise of the Over-Allotment Option, subject to a reduced fee of 3.5% of the gross proceeds for Units sold by the Underwriter to certain purchasers designated by the Company on the President's list (the "President's List") and (ii) non-transferable warrants (the "Underwriter's Warrants") to purchase up to 7% of the number of Units sold in the Offering, including any additional Units issued upon the Underwriter's exercise of the Over-Allotment Option, subject to a reduced number of Underwriter's Warrants equal to 3.5% of the Units sold by the Underwriter to purchasers on the President's List. Each Underwriter's Warrant will entitle the holder thereof to purchase one Unit at an exercise price equal to the Offering Price for 36 months from the Closing Date.